Multiple Chest Nodules on Computed Tomography Scan

Jeannine M. Brant

Diane Jones

leukemia, lymphocytic, chronic, immunosuppression, aspergillosis, amphotericin B
CJON 2003, 7(6), 697-698. DOI: 10.1188/03.CJON.697-698

Jump to a section

    References

    Bartlett, J. G. 2000. Aspergillosis update. Medicine, 79, 281-282.

    Denning, D. W. 1996. Therapeutic outcomes in invasive aspergillosis. Clinical Infectious Diseases, 23, 608-615.

    Groll, A. H., & Walsh, T. J. 2002. Invasive fungal infections in the neutropenic cancer patient: Current approaches and future strategies. Infections in Medicine, 19, 326-334.

    Lortholary, O., & Dupont, B. 1997. Antifungal prophylaxis during neutropenia and immunodeficiency. Clinical Microbiology Reviews, 10, 477-504.

    Slavin, M. A., Osborne, B., Adams R., Levenstein, M. J., Schoch, H. G., Feldman, A. R., et al. 1995. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-A prospective, double-blind study. Journal of Infectious Diseases, 171, 1545-1552.

    Soubani, A. O., & Chandrasekar, P. H. 2002. The clinical spectrum of pulmonary aspergillosis. Chest, 121, 1988-1999.

    Stevens, D. A., Kan, V. L., Judson, M. A., Morrison, V. A., Dummer, S., Denning, D. W., et al. 2000. Practice guidelines for diseases caused by aspergillosis. Infectious Diseases Society of America. Clinical Infectious Diseases, 30, 696-709.